Literature DB >> 17202280

Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci.

Liselotte Högberg1, Patricia Geli, Håkan Ringberg, Eva Melander, Marc Lipsitch, Karl Ekdahl.   

Abstract

Using data from an ongoing Swedish intervention project, the observed durations of nasopharyngeal carriage of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) (MIC of penicillin G of >or=0.5 microg/ml) stratified by both pneumococcal serogroup and age of the carrier were compared. The means and 95% confidence intervals (CIs) were estimated by fitting a gamma distribution to the observed duration of carriage for each age and serogroup stratum. The mean observed duration of carriage for all cases was 37 days (95% CI, 35 to 38 days). Children below the age of 5 years carried PNSP for significantly longer periods (43 days; 95% CI, 41 to 45 days) compared with older individuals (25 days; 95% CI, 24 to 27 days). There were also differences within the group of cases below the age of 5 years, as the duration of carriage became significantly shorter for each increasing age step: <1, 1 to 2, and 3 to 4 years. In addition, patients <5 years of age carried serogroups 9 and 14 for significantly shorter periods than groups 6 and 23. Serogroup 9 was also carried for significantly shorter periods than group 19. For patients aged 5 years or older, no significant difference in carriage duration for different ages or serogroups could be noted. As young children have the longest duration of PNSP carriage, interventions aiming to reduce the prevalence in this group are of great importance. The results highlight the importance of taking both serogroup and age of the carriers into account when studying the dynamics of pneumococcal transmission in young children.

Entities:  

Mesh:

Year:  2007        PMID: 17202280      PMCID: PMC1829115          DOI: 10.1128/JCM.01913-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

Authors:  K Ekdahl; I Ahlinder; H B Hansson; E Melander; S Mölstad; M Söderström; K Persson
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

2.  Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study.

Authors:  J N Dowling; P R Sheehe; H A Feldman
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

3.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Authors:  S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

4.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Authors:  Michael R Jacobs; David Felmingham; Peter C Appelbaum; Reuben N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2003-07-15       Impact factor: 5.790

Review 5.  From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae.

Authors:  H De Lencastre; A Tomasz
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 6.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Authors:  D Bogaert; R De Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

7.  Estimating the transmission parameters of pneumococcal carriage in households.

Authors:  A Melegaro; N J Gay; G F Medley
Journal:  Epidemiol Infect       Date:  2004-06       Impact factor: 2.451

8.  Immunologic response to pneumococcal polysaccharide vaccine in infants.

Authors:  J L Sloyer; J H Ploussard; L J Karr; G D Schiffman
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1980 May-Jun

9.  The immune response to pneumococcal proteins during experimental human carriage.

Authors:  Tera L McCool; Thomas R Cate; Gregory Moy; Jeffrey N Weiser
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

10.  Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, Sweden.

Authors:  Eva Melander; Hans-Bertil Hansson; Sigvard Mölstad; Kristina Persson; Håkan Ringberg
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  63 in total

Review 1.  Next generation pneumococcal vaccines.

Authors:  Kristin L Moffitt; Richard Malley
Journal:  Curr Opin Immunol       Date:  2011-04-21       Impact factor: 7.486

2.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

Review 3.  Patterns of antigenic diversity and the mechanisms that maintain them.

Authors:  Marc Lipsitch; Justin J O'Hagan
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

Review 4.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

5.  Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.

Authors:  Marc Lipsitch; Osman Abdullahi; Alexander DʼAmour; Wen Xie; Daniel M Weinberger; Eric Tchetgen Tchetgen; J Anthony G Scott
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

6.  Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.

Authors:  Sarah Cobey; Marc Lipsitch
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

7.  Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression.

Authors:  Elizabeth A Joyce; Stephen J Popper; Stanley Falkow
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

8.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

Authors:  Caroline Colijn; Ted Cohen; Christophe Fraser; William Hanage; Edward Goldstein; Noga Givon-Lavi; Ron Dagan; Marc Lipsitch
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

9.  Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania.

Authors:  Alexander N J White; Victoria Ng; C Victor Spain; Caroline C Johnson; Laura M Kinlin; David N Fisman
Journal:  BMC Infect Dis       Date:  2009-12-04       Impact factor: 3.090

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.